From Nature: Computer-Calculated Compounds
The aim of BERG’s approach is to identify potential treatments on the basis of the precise biological causes of disease. “We are turning the drug-discovery paradigm upside down by using patient-driven biology and data to derive more predictive hypotheses, rather than the traditional trial-and-error approach,” says Niven R. Narain, BERG’s co-founder and CEO.
This Nature piece goes on to note how researchers are using AI to discover drugs, and specifically highlight’s BERG and Niven R. Narain in their “Spotlight” feature.